Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 183
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Poult Sci ; 87(7): 1276-80, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18577605

RESUMEN

The effect of water supplementation of KCl on performance of heat-stressed Hubbard broilers was evaluated in the present experiment. The 3 experimental treatments (i.e., control, 0.3 and 0.6% KCl) were allocated to 3 replicates of 15 birds each. The control group was kept on dugout tap water, whereas the other 2 groups were supplied water supplemented with 0.3 and 0.6% KCl (wt/vol) by supplementing 3 and 6 g of KCl, respectively, per liter of drinking water. Broilers were provided ad libitum access to feed and water for the experimental period of 7 to 42 d of age and kept in open-sided house. The birds were reared under continuous thermostress (minimum 28.2 +/- 1.02 and maximum 37.5 +/- 0.78 degrees C) environment. Supplementing drinking water with 0.6% KCl reduced panting-phase blood pH to 7.31 and significantly increased live BW gain by 14.5 (P = 0.036) and 7.9% (P = 0.029) at 28 and 42 d of age, respectively, relative to control. An improved (P = 0.04) feed:gain and lowered body temperature were noted in groups supplemented with 0.6% KCl as compared with control and 0.3% KCl. Enhanced physiological adaptation with 0.6% KCl was evidenced by a more favorable pH during the panting phase in the present study. These findings demonstrated a possibility of better broiler live performance through KCl supplementation under conditions of severe heat stress (35 to 38 degrees C).


Asunto(s)
Pollos/crecimiento & desarrollo , Calor , Cloruro de Potasio/administración & dosificación , Cloruro de Potasio/farmacología , Estrés Fisiológico/tratamiento farmacológico , Agua/análisis , Animales , Relación Dosis-Respuesta a Droga , Vías de Administración de Medicamentos , Masculino , Aumento de Peso/efectos de los fármacos
2.
J Ethnopharmacol ; 118(1): 118-26, 2008 Jun 19.
Artículo en Inglés | MEDLINE | ID: mdl-18485640

RESUMEN

AIM OF THE STUDY: The aim of this study was to investigate whether Sutherlandia frutescens, subsp. microphylla (family: Fabaceae/Leguminosa), which is traditionally used to treat symptoms of chronic stress generally associated with increased circulating glucocorticoids, influences the biosynthesis of these glucocorticoids. METHODS: We investigated the interaction of Sutherlandia frutescens with cytochrome P450 enzymes, CYP17 and CYP21, which catalyse key reactions in glucocorticoid biosynthesis. The binding of progesterone and pregnenolone to these enzymes and their metabolism were assayed in the presence of extracts and the bioactive compounds, l-canavanine, pinitol, GABA, flavonoids and triterpenoid glucosides present in the shrub. RESULTS: While the aqueous and methanol extracts inhibited the type I progesterone-induced difference spectrum (p<0.05), inhibition of pregnenolone binding (p=0.25) was negligible, with the aqueous extract exhibiting greater inhibition. The triterpenoid fraction inhibited both the type I pregnenolone- and progesterone-induced difference spectra and elicited a type II difference spectrum in the absence of substrate. Both pregnenolone and progesterone metabolism were inhibited by the aqueous extract, the inhibition of CYP21 being greater than that of CYP17, influencing the flux through glucocorticoid precursor pathways. CONCLUSION: This attenuation of adrenal P450 enzymes may thus demonstrate a possible mechanism by which Sutherlandia frutescens reduces glucocorticoid levels and alleviates symptoms associated with stress.


Asunto(s)
Glándulas Suprarrenales/enzimología , Sistema Enzimático del Citocromo P-450/efectos de los fármacos , Fabaceae/química , Extractos Vegetales/farmacología , Animales , Sistema Enzimático del Citocromo P-450/metabolismo , Medicinas Tradicionales Africanas , Extractos Vegetales/química , Pregnenolona/metabolismo , Progesterona/metabolismo , Unión Proteica/efectos de los fármacos , Ovinos , Estrés Fisiológico/tratamiento farmacológico , Estrés Fisiológico/fisiopatología
3.
Pharmacol Biochem Behav ; 89(4): 572-80, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18367239

RESUMEN

Xiaobuxin-Tang (XBXT), a traditional Chinese herbal decoction, has been used for the treatment of depressive disorders for centuries in China. Herein, we explored the antidepressant-like effect and its monoaminergic mechanism of the total flavonoids (XBXT-2) isolated from the extract of XBXT. In present study, single XBXT-2 (25, 50, 100 mg/kg, p.o.) administration significantly potentiated the mouse head-twitch response induced by 5-hydroxytryptophan (5-HTP, a metabolic precursor to serotonin), and also, decreased the immobility time in mouse tail suspension test, which was completely prevented by p-chlorophenylalanine (PCPA, an inhibitor of serotonin synthesis) pretreatment. However, single treatment with XBXT-2 had no effect on yohimbine toxicity and high dose of apomorphine-induced hypothermia in mice. These results indicated that acute treatment with XBXT-2 produced serotonergic, but not noradrenergic activation. In addition, chronic XBXT-2 (25, 50 mg/kg, p.o., 28 days) treatments significantly reversed the depressive-like behaviors in chronically mildly stressed (CMS) rats, including the reduced sucrose preference, deficient locomotor activity and prolonged latency to novelty-suppressed feeding. Furthermore, XBXT-2 normalized the neurotransmitter changes, including the decreased serotonin (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) levels in hippocampus and prefrontal cortex in CMS rats. These findings confirm the antidepressant-like effect of XBXT-2 in CMS model of rats, which may be primarily based on its serotonergic activation.


Asunto(s)
Antidepresivos/farmacología , Medicamentos Herbarios Chinos/farmacología , Flavonoides/farmacología , Serotonina/metabolismo , Animales , Antidepresivos/aislamiento & purificación , Apomorfina/toxicidad , Conducta Animal/efectos de los fármacos , Depresión/tratamiento farmacológico , Depresión/fisiopatología , Depresión/psicología , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/aislamiento & purificación , Conducta Alimentaria/efectos de los fármacos , Fenclonina/farmacología , Flavonoides/aislamiento & purificación , Humanos , Hipotermia/inducido químicamente , Hipotermia/tratamiento farmacológico , Masculino , Ratones , Ratones Endogámicos ICR , Actividad Motora/efectos de los fármacos , Fitoterapia , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Ratas , Ratas Sprague-Dawley , Estrés Fisiológico/tratamiento farmacológico , Yohimbina/toxicidad
4.
Phytomedicine ; 15(6-7): 437-46, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18162386

RESUMEN

The present study was carried out to study mechanism of adaptogenic activity of seabuckthorn leaf extract, administered orally in rats both in single and five doses at a dose of 100mg/kg body weight 30min prior to C-H-R exposure. The efficacy of the extract was studied on circulating energy fuels, lipid peroxidation and anti-oxidant parameters in rats on attaining the T(rec) 23 degrees C during C-H-R exposure and after recovery (T(rec) 37 degrees C) from C-H-R induced hypothermia. Single dose treatment in rats restricted rise in blood malondialdehyde (MDA) levels and decrease in glutathione (GSH) and catalase (CAT) levels. Both single and five doses also restricted the rise in serum free fatty acids (FFA) and lactate dehydrogenase (LDH) levels on attaining T(rec) 23 degrees C during C-H-R exposure, suggesting more efficient utilization of FFA for energy production and better maintained cell membrane permeability. This suggested that the adaptogenic activity of the extract might be due to its anti-oxidative activity, maintained blood glucose levels, better utilization of FFA and improved cell membrane permeability.


Asunto(s)
Antioxidantes/metabolismo , Hippophae , Peroxidación de Lípido/efectos de los fármacos , Extractos Vegetales/uso terapéutico , Estrés Fisiológico/tratamiento farmacológico , Animales , Glucemia/metabolismo , Ácidos Grasos no Esterificados/sangre , Hipotermia/tratamiento farmacológico , Hipoxia/tratamiento farmacológico , L-Lactato Deshidrogenasa/sangre , Ácido Láctico/sangre , Masculino , Fitoterapia , Extractos Vegetales/farmacología , Hojas de la Planta , Ratas , Ratas Sprague-Dawley , Estrés Fisiológico/sangre
5.
Neuropharmacology ; 54(1): 161-71, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17714742

RESUMEN

Footshock stress induces both endocannabinoid mobilization and antinociception. The present studies investigated behavioral plasticity in cannabinoid antinociceptive mechanisms following repeated activation using the tail-flick test. A secondary objective was to ascertain whether blockade of stress antinociception by the CB(1) antagonist rimonabant could be attributed to changes in locomotor activity. The cannabinoid agonist WIN55,212-2 induced hypoactivity in the open field relative to vehicle-treated controls. By contrast, rimonabant, administered at a dose that virtually eliminated endocannabinoid-mediated stress antinociception, failed to alter locomotor behavior (i.e. time resting, ambulatory counts, distance traveled) in rats subjected to the same stressor. Rats exposed acutely to footshock were hypersensitive to the antinociceptive effects of WIN55,212-2 and Delta(9)-tetrahydrocannabinol (Delta(9)-THC). The converse was also true; acute Delta(9)-THC and WIN55,212-2 administration potentiated stress antinociception, suggesting a bidirectional sensitization between endocannabinoid-mediated stress antinociception and exogenous cannabinoid antinociception. Stress antinociception was also attenuated following chronic relative to acute treatment with WIN55,212-2 or Delta(9)-THC. Repeated exposure to footshock (3 min/day for 15 days), however, failed to attenuate antinociception induced by either footshock stress or WIN55,212-2. Our results demonstrate that endocannabinoid-mediated stress antinociception cannot be attributed to motor suppression. Our results further identify a functional plasticity of the cannabinoid system in response to repeated activation. The existence of cross-sensitization between endocannabinoid-mediated stress antinociception and exogenous cannabinoid antinociception suggests that these phenomena are mediated by a common mechanism. The observation of stress-induced hypersensitivity to effects of exogenous cannabinoids may have clinical implications for understanding marijuana abuse liability in humans.


Asunto(s)
Analgésicos/uso terapéutico , Benzoxazinas/uso terapéutico , Moduladores de Receptores de Cannabinoides/metabolismo , Dronabinol/uso terapéutico , Endocannabinoides , Morfolinas/uso terapéutico , Naftalenos/uso terapéutico , Piperidinas/uso terapéutico , Pirazoles/uso terapéutico , Estrés Fisiológico/tratamiento farmacológico , Análisis de Varianza , Animales , Conducta Animal , Moduladores de Receptores de Cannabinoides/antagonistas & inhibidores , Esquema de Medicación , Tolerancia a Medicamentos/fisiología , Electrochoque/efectos adversos , Masculino , Actividad Motora/efectos de los fármacos , Dimensión del Dolor , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción/efectos de los fármacos , Rimonabant , Estrés Fisiológico/etiología , Estrés Fisiológico/fisiopatología , Factores de Tiempo
6.
Prog Neuropsychopharmacol Biol Psychiatry ; 32(3): 715-25, 2008 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-18093712

RESUMEN

Honokiol and magnolol are the main constituents simultaneously identified in the barks of Magnolia officinalis, which have been used in traditional Chinese medicine to treat a variety of mental disorders including depression. In the present study, we reported on the antidepressant-like effects of oral administration of the mixture of honokiol and magnolol in well-validated models of depression in rodents: forced swimming test (FST), tail suspension test (TST) and chronic mild stress (CMS) model. The mixture of honokiol and magnolol significantly decreased immobility time in the mouse FST and TST, and reversed CMS-induced reduction in sucrose consumption to prevent anhedonia in rats. However, this mixture was unable to affect ambulatory or rearing behavior in the mouse open-field test. CMS induced alterations in 5-hydroxytryptamine (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) levels in various brain regions of rats. An increase in serum corticosterone concentrations and a reduction in platelet adenylyl cyclase (AC) activity were simultaneously found in the CMS rats. The mixture of honokiol and magnolol at 20 and 40 mg/kg significantly attenuated CMS-induced decreases of 5-HT levels in frontal cortex, hippocampus, striatum, hypothalamus and nucleus accumbens. And it markedly increased 5-HIAA levels in frontal cortex, striatum and nucleus accumbens at 40 mg/kg and in frontal cortex at 20 mg/kg in the CMS rats. A subsequent reduction in 5-HIAA/5-HT ratio was found in hippocampus and nucleus accumbens in the CMS rats receiving this mixture. Furthermore, the mixture of honokiol and magnolol reduced elevated corticosterone concentrations in serum to normalize the hypothalamic-pituitary-adrenal (HPA) hyperactivity in the CMS rats. It also reversed CMS-induced reduction in platelet AC activity, via upregulating the cyclic adenosine monophosphate (cAMP) pathway. These results suggested that the mixture of honokiol and magnolol possessed potent antidepressant-like properties in behaviors involved in normalization of biochemical abnormalities in brain 5-HT and 5-HIAA, serum corticosterone levels and platelet AC activity in the CMS rats. Our findings could provide a basis for examining directly the interaction of the serotonergic system, the HPA axis and AC-cAMP pathway underlying the link between depression and treatment with the mixture of honokiol and magnolol.


Asunto(s)
Antidepresivos/uso terapéutico , Compuestos de Bifenilo/uso terapéutico , Lignanos/uso terapéutico , Magnolia/química , Fitoterapia/métodos , Estrés Fisiológico/tratamiento farmacológico , Animales , Conducta Animal/efectos de los fármacos , Corticosterona/sangre , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Conducta Exploratoria/efectos de los fármacos , Suspensión Trasera/métodos , Ácido Hidroxiindolacético/sangre , Masculino , Ratones , Ratones Endogámicos ICR , Ratas , Ratas Wistar , Serotonina/sangre , Estrés Fisiológico/sangre , Natación
9.
J Nat Prod ; 70(9): 1410-6, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17850106

RESUMEN

Three new compounds, ocimumosides A (1) and B (2) and ocimarin (3), were isolated from an extract of the leaves of holy basil (Ocimum sanctum), together with eight known substances, apigenin, apigenin-7-O-beta-D-glucopyranoside, apigenin-7-O-beta-D-glucuronic acid ( 4), apigenin-7- O-beta- d-glucuronic acid 6''-methyl ester, luteolin-7-O-beta-D-glucuronic acid 6''-methyl ester, luteolin-7-O-beta-D-glucopyranoside, luteolin-5-O-beta-D-glucopyranoside, and 4-allyl-1-O-beta-D-glucopyronosyl-2-hydroxybenzene (5), and two known cerebrosides. The structures of the new compounds were determined on the basis of extensive 1D and 2D NMR spectroscopic analysis. The new compounds (1- 3) and the known compounds 4 and 5 were screened at a dose of 40 mg/kg body weight for acute stress-induced biochemical changes in male Sprague-Dawley rats. Compound 1 displayed promising antistress effects by normalizing hyperglycemia, plasma corticosterone, plasma creatine kinase, and adrenal hypertrophy. Compounds 2 and 5 were also effective in normalizing most of these stress parameters. In contrast, compounds 3 and 4 were ineffective in normalizing any of these effects.


Asunto(s)
Cerebrósidos/aislamiento & purificación , Cerebrósidos/farmacología , Cumarinas/aislamiento & purificación , Cumarinas/farmacología , Ocimum/química , Plantas Medicinales/química , Estrés Fisiológico/tratamiento farmacológico , Animales , Glucemia/análisis , Cerebrósidos/química , Corticosterona/análisis , Corticosterona/sangre , Cumarinas/química , Creatina Quinasa/análisis , Modelos Animales de Enfermedad , India , Masculino , Estructura Molecular , Resonancia Magnética Nuclear Biomolecular , Ratas , Ratas Sprague-Dawley
10.
Food Chem Toxicol ; 45(12): 2426-33, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17673345

RESUMEN

The present study was carried out to investigate mechanism of adaptogenic activity of seabuckthorn dry leaves aqueous lyophilized extract, administered in rats at a dose of 100 mg/kg body weight prior to cold (5 degrees C)-hypoxia (428 mmHg)-restraint (C-H-R) exposure up to fall of T(rec) 23 degrees C and recovery (T(rec) 37 degrees C) from C-H-R induced hypothermia. The effect of extract treatment was studied on key metabolic regulatory enzymes in blood, liver and muscle and tissue glycogen in rats on attaining T(rec) 23 degrees C and post stress recovery of T(rec) 37 degrees C. In control rats during C-H-R exposure on attaining T(rec) 23 degrees C there was significant decrease in enzyme activities of blood hexokinase (HK), citrate synthase (CS) and glucose-6-phosphate dehydrogenase (G-6-PD); liver CS; and in muscle glycogen, and CS and G-6-PD activities. In control rats on recovery of T(rec) 37 degrees C there was also a significant decrease in liver and muscle glycogen levels along with decreased enzyme activities of blood G-6-PD; liver CS; and liver and muscle G-6-PD. This suggested that during severe stressful exposure to C-H-R and post stress recovery the aerobic metabolism as well as hexose monophosphate (HMP) pathway is suppressed. The single and five doses extract treatment restricted the decrease or better maintained tissue glycogen and enzyme activities, viz. HK, phosphofructokinase (PFK), CS and G-6-PD, in blood, liver and muscle, during C-H-R exposure (T(rec) 23 degrees C) and recovery of T(rec) 37 degrees C. The results suggest that seabuckthorn extract treatment caused a trend for shifting anaerobic metabolism to aerobic during C-H-R exposure and post stress recovery.


Asunto(s)
Adaptación Fisiológica/efectos de los fármacos , Hippophae , Hipotermia/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/farmacología , Administración Oral , Animales , Frío , Relación Dosis-Respuesta a Droga , Hipotermia/sangre , Hipotermia/fisiopatología , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/metabolismo , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico , Hojas de la Planta , Ratas , Ratas Sprague-Dawley , Restricción Física , Estrés Fisiológico/tratamiento farmacológico , Estrés Fisiológico/fisiopatología
11.
Phytother Res ; 21(11): 1061-5, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17639553

RESUMEN

Lipophilic extracts of Ginkgo biloba L. leaves were tested for their possible role on rodent models of depression and stress. Lipophilic extracts of Ginkgo leaves (LEG) at (50 and 100 mg/kg, p.o.) exhibited dose dependent, significant antidepressant activity in the behavioral despair test and learned helplessness rodent model of depression. The activities were comparable to that of imipramine (15 mg/kg) and EGb 761 (50 mg/kg). In the cold immobilization stress induced gastric ulcer model of stress, only the LEG showed a significant reduction in the ulcer index. GC-MS characterization of this bioactive extract was found to be rich in a group of 6-alkyl salicylates (6-AS), along with a fatty alcohol, fatty acids and cardanols. The n-heptadecenyl salicylate represented 60% of the 6-AS. Notable was the absence of dihydroxy alkylphenols which are linked to allergic reactions similar to the urushiols present in poison ivy. In commercial products of Ginkgo, these dihydroxy phenols as well as the favorable 6-AS are removed during enrichment of flavonol glycosides and terpenic lactones. The current findings suggest that intact carboxylic acid groups containing 6-AS are the bioactive components of the lipophilic extract of Ginkgo leaves with antidepressant and antistress activities.


Asunto(s)
Antidepresivos/análisis , Ginkgo biloba/química , Fitoterapia , Extractos Vegetales/uso terapéutico , Estrés Fisiológico/tratamiento farmacológico , Estrés Psicológico/tratamiento farmacológico , Animales , Cromatografía de Gases y Espectrometría de Masas , Extractos Vegetales/química , Hojas de la Planta/química , Ratas
12.
Phytother Res ; 21(12): 1187-92, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17639560

RESUMEN

The individual and combined antistress effects of the fruit of Schizandra chinensis and the radix of Scutellaria baicalensis were evaluated using a mouse acute stress model. Stress consisted of immobilization and electric foot shocks over 5 days. Mice were treated with herbal extracts for 7 days before exposing the animals to stress. Before each stressor presentation, the mice were treated with each herbal extract. Reduced locomotor activity and the percentage of time spent in the open arms of an elevated plus-maze under stress were recovered by treatment with the extract containing equal amounts of S. chinensis and S. baicalensis (CB11) at 200 and 400 mg/kg (p < 0.05). The effects of CB11 were greater than the effects of S. chinensis or S. baicalensis alone. CB11 treatment (100, 200 and 400 mg/kg) significantly reduced serum corticosterone levels (p < 0.05). Spleen size and the serum interleukin-2 level decreases induced by stress were prevented by CB11 (200 mg/kg) (p < 0.05). Taken together, these results suggest that S. chinensis and S. baicalensis in equal amounts could be used to treat stress disorders, in part, by preventing corticosterone and IL-2 level changes and ameliorating stress-related behavior parameters.


Asunto(s)
Fitoterapia , Extractos Vegetales/uso terapéutico , Schisandra , Estrés Fisiológico/tratamiento farmacológico , Estrés Psicológico/tratamiento farmacológico , Animales , Corticosterona/sangre , Interleucina-2/sangre , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Ratones , Ratones Endogámicos ICR , Actividad Motora/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Extractos Vegetales/farmacología , Restricción Física , Scutellaria baicalensis , Bazo/patología , Estrés Fisiológico/sangre , Estrés Fisiológico/patología , Estrés Psicológico/sangre , Estrés Psicológico/patología
13.
J Physiol Anthropol ; 26(3): 349-54, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17641454

RESUMEN

To clarify the influences of ethnic and regional characteristics, and differences in perception on the cedrol effect on autonomic nerve activity, we compared women in their 20s-40s in Norway, Thailand, and Japan. A questionnaire survey of sense of stress and sleep conditions was performed at the same time. The degree of perceived stress, using a 30-item checklist, was highest in Japanese women. The mean stress score exceeded 5.0 in Japanese women, significantly higher than in Thai women (p<0.05) and Norwegian women (p<0.01). Sleeping time was shortest in Japanese women in all generations among the three countries. As the index of autonomic nervous activity, the miosis rate (ratio of pupil-diameter variation after light stimulus to initial pupil diameter) in pupillary light reflex was measured before and after cedrol inhalation. The miosis rate significantly increased after cedrol exposure compared to that before exposure in all three countries, suggesting that the parasympathetic nervous system became dominant. These findings suggested that cedrol produces a sedative effect in people of the three countries despite differences in the ethnic and living environments.


Asunto(s)
Sistema Nervioso Autónomo/efectos de los fármacos , Fitoterapia , Estrés Fisiológico/tratamiento farmacológico , Terpenos/uso terapéutico , Tracheophyta , Administración por Inhalación , Adulto , Aerosoles , Pueblo Asiatico/genética , Sistema Nervioso Autónomo/fisiología , Femenino , Humanos , Japón , Noruega , Sesquiterpenos Policíclicos , Estrés Fisiológico/genética , Encuestas y Cuestionarios , Terpenos/administración & dosificación , Tailandia , Población Blanca/genética
14.
Free Radic Res ; 41(7): 829-38, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17577744

RESUMEN

During effort overstress the reactive oxygen species act chiefly on unsaturated lipids, inducing the formation of certain peroxidation products. We have investigated malondialdehide (MDA), platelet adhesion index, and immunological activation parameters during effort overstress and administration of vitamins E and C. Biochemical measurements were performed on erythrocytes and heart homogenate. In the vitamin E supplemented group, the platelet adhesion index was constantly correlated with the MDA level (p < 0.001). There is a protecting effect concerning the oxidative stress in animals pretreated with vitamin E and C, which is expressed through the diminution of the MDA quantity both in the erythrocyte and in the heart. The physical effort required by swimming led to a decrease in the NBT test values and in the activity of the serum complement. The steady administration of vitamin E in the effort overstress, due to its antioxidant properties, causes the progressive decrease in peroxidation and platelet adhesion.


Asunto(s)
Antioxidantes/uso terapéutico , Adhesividad Plaquetaria/fisiología , Estrés Fisiológico/tratamiento farmacológico , Análisis de Varianza , Animales , Proteínas del Sistema Complemento/metabolismo , Modelos Animales de Enfermedad , Masculino , Malondialdehído/metabolismo , Neutrófilos/efectos de los fármacos , Neutrófilos/fisiología , Fagocitosis/efectos de los fármacos , Adhesividad Plaquetaria/efectos de los fármacos , Ratas , Ratas Wistar , Estrés Fisiológico/sangre , Vitamina E/uso terapéutico
15.
J Nutr ; 137(6 Suppl 2): 1687S-1692S, 2007 06.
Artículo en Inglés | MEDLINE | ID: mdl-17513448

RESUMEN

Arginine is a nonessential amino acid in the normal physiological state that becomes conditionally essential during periods of hypermetabolic stress. Recent literature supports the hypothesis that arginine plays an important role in the intermediary metabolism of the critically ill patient. Current critical care literature is conflicting on arginine use in the clinical setting, with some proposing it as a panacea, whereas others report it as poison. Multiple individual reports and at least 5 major meta-analyses using combinations of immune-modulating nutrients have reported mostly beneficial results, but few have evaluated the effects of arginine when given as a single supplemental nutrient. This review attempts to objectively analyze the literature and evaluate the potential role of arginine in the critical care setting.


Asunto(s)
Arginina/metabolismo , Arginina/uso terapéutico , Enfermedad Crítica , Estrés Fisiológico/tratamiento farmacológico , Estrés Fisiológico/metabolismo , Arginina/inmunología , Cuidados Críticos/métodos , Humanos , Estrés Fisiológico/inmunología
16.
CNS Drug Rev ; 13(1): 107-36, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17461893

RESUMEN

The NOP receptor (formerly referred to as opiate receptor-like 1, ORL-1, LC132, OP(4), or NOP(1)) is a G protein-coupled receptor that shares high homology to the classic opioid MOP, DOP, and KOP (mu, delta, and kappa, respectively) receptors and was first cloned in 1994 by several groups. The NOP receptor remained an orphan receptor until 1995, when the endogenous neuropeptide agonist, known as nociceptin or orphanin FQ (N/OFQ) was isolated. Five years later, a group at Hoffmann-La Roche reported on the selective, nonpeptide NOP agonist Ro 64-6198, which became the most extensively published nonpeptide NOP agonist and a valuable pharmacological tool in determining the potential of the NOP receptor as a therapeutic target. Ro 64-6198 is systemically active and achieves high brain penetration. It has subnanomolar affinity for the NOP receptor and is at least 100 times more selective for the NOP receptor over the classic opioid receptors. Ro 64-6198 ranges from partial to full agonist, depending on the assay. Preclinical data indicate that Ro 64-6198 may have broad clinical uses, such as in treating stress and anxiety, addiction, neuropathic pain, cough, and anorexia. This review summarizes the pharmacology and preclinical data of Ro 64-6198.


Asunto(s)
Evaluación Preclínica de Medicamentos , Imidazoles/farmacología , Receptores Opioides/agonistas , Compuestos de Espiro/farmacología , Animales , Ansiedad/tratamiento farmacológico , Humanos , Imidazoles/efectos adversos , Imidazoles/química , Imidazoles/uso terapéutico , Dolor/tratamiento farmacológico , Compuestos de Espiro/efectos adversos , Compuestos de Espiro/química , Compuestos de Espiro/uso terapéutico , Estrés Fisiológico/tratamiento farmacológico , Receptor de Nociceptina
17.
Phytomedicine ; 14(7-8): 523-9, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17085027

RESUMEN

Depression is related to alterations of the monoamine oxidase (MAO), hypothalamic-pituitary-adrenal (HPA) axis, and oxidative systems, and some antidepressants achieve their therapeutic effects through alteration of following biochemical markers of depression: MAO-A and MAO-B activities, cortisol levels, superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels. The seeds of Psoralea corylifolia, otherwise known as Buguzhi, have long been used for treatments of various symptoms associated with aging in China. Furocoumarins are the most widespread secondary metabolites in this species. The present study was designed to evaluate the potential antidepressant-like activity of total furocoumarins of P. corylifolia (TFPC) in the chronic mild stress (CMS) model of depression. Mice subjected to CMS exhibited a reduction in sucrose intake. Conversely, brain MAO-A and MAO-B activities, plasma cortisol levels, and liver SOD activity and MDA levels were increased following CMS exposures. The time-course for reversal of CMS-induced deficits in sucrose consumption by TFPC was dose-dependent. Thus, the statistically significant effect of the higher dose of TFPC (50 mg/kg body wt.) was observed after 3 days of treatment, while 6 days of treatment were required in the group receiving a lower dose (30 mg/kg body wt.) of TFPC. TFPC reversed these biochemical changes. These results suggest that TFPC may possess potent and rapid antidepressant properties that are mediated via MAO, the HPA axis and oxidative systems and these antidepressant actions could make TFPC a potentially valuable drug for the treatment of depression in the elderly.


Asunto(s)
Antidepresivos/farmacología , Depresión/tratamiento farmacológico , Modelos Animales de Enfermedad , Furocumarinas/farmacología , Psoralea/química , Semillas/química , Estrés Fisiológico/tratamiento farmacológico , Animales , Conducta Alimentaria , Furocumarinas/química , Furocumarinas/aislamiento & purificación , Hidrocortisona/sangre , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , Ratones , Ratones Endogámicos ICR , Monoaminooxidasa/metabolismo , Fitoterapia , Extractos Vegetales/química , Extractos Vegetales/farmacología , Sacarosa , Superóxido Dismutasa
18.
Acta Neurobiol Exp (Wars) ; 66(2): 129-38, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16886723

RESUMEN

This study aimed at verifying a hypothesis that St. John's wort (Hypericum perforatum) alleviates stress-induced memory impairments. Administration of Hypericum perforatum (350 mg kg(-1) daily for 21 days) significantly enhanced recall of passive avoidance behavior (PAB), but had no effect on the acquisition of conditioned avoidance responses (CARs). Rats stressed chronically (2 h daily for 21 days) displayed diminished recall of the PAB and this effect was abolished by St John's wort. Chronic administration of the "equivalent" to the stress dose of exogenous corticosterone (5 mg kg(-1) daily for 21 days) also impaired recall of PAB, and this effect was also reversed by Hypericum perforatum. None of our treatments produced significant motor coordination impairments as tested in a 'chimney' test. It appears that H. perforatum prevents stress-induced deterioration of memory in rats.


Asunto(s)
Hypericum , Recuerdo Mental/efectos de los fármacos , Fitoterapia , Estrés Fisiológico/tratamiento farmacológico , Animales , Antiinflamatorios/farmacología , Reacción de Prevención/efectos de los fármacos , Enfermedad Crónica , Condicionamiento Psicológico/efectos de los fármacos , Corticosterona/farmacología , Modelos Animales de Enfermedad , Masculino , Actividad Motora/efectos de los fármacos , Polvos , Ratas , Ratas Wistar , Restricción Física , Estrés Fisiológico/etiología
19.
Indian J Exp Biol ; 44(7): 574-9, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16872048

RESUMEN

The herbal formulation, AVM is a proprietary formula that consists of extracts of herbs that have been used in Indian traditional medicine to promote physical and mental health, improve defense mechanisms of the body and enhance longevity. AVM (500 and 1000 mg/kg) was tested for its adaptogenic activity by determining antistress, anabolic and immunomodulatory effects. In antistress activity, pretreatment with AVM significantly attenuated the changes in ascorbic acid (from blood and adrenal), cortisol (from plasma and adrenal) and adrenal gland weights induced due to restrain stress (physical immobilization). Its antistress effect at 1000 mg/kg was comparable to that of diazepam (5 mg/kg) treated group. Leucopenia, and anemia induced by cyclophosphamide (CYP) was shown to reduce significantly by AVM. Treatment of AVM + CYP had increased spleen and thymus weights significantly as compared to CYP alone treated group. The anabolic activity was evaluated by weight gain of the levator ani muscle, ventral prostrate gland and seminal vesicles in rats as compared to untreated control.


Asunto(s)
Adaptación Fisiológica/efectos de los fármacos , Anabolizantes/uso terapéutico , Factores Inmunológicos/uso terapéutico , Medicina Ayurvédica , Preparaciones de Plantas/uso terapéutico , Adaptación Fisiológica/inmunología , Anabolizantes/administración & dosificación , Anabolizantes/toxicidad , Anemia/sangre , Anemia/inmunología , Anemia/prevención & control , Animales , Peso Corporal/efectos de los fármacos , Ciclofosfamida/efectos adversos , Femenino , Factores Inmunológicos/administración & dosificación , Factores Inmunológicos/toxicidad , Leucopenia/sangre , Leucopenia/inmunología , Leucopenia/prevención & control , Masculino , Ratones , Ratones Endogámicos , Tamaño de los Órganos/efectos de los fármacos , Preparaciones de Plantas/administración & dosificación , Preparaciones de Plantas/toxicidad , Medicina Preventiva , Ratas , Ratas Wistar , Restricción Física , Estrés Fisiológico/sangre , Estrés Fisiológico/tratamiento farmacológico , Estrés Fisiológico/fisiopatología , Pruebas de Toxicidad Aguda
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA